Pancuronium and Sucralfate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pancuronium (pancuronium bromide) and Sucralfate (sucralfate). Common drug interactions include pyrexia among females and sepsis among males.
The phase IV clinical study analyzes what interactions people have when they take Pancuronium and Sucralfate. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.
What is Pancuronium?
Pancuronium has active ingredients of pancuronium bromide. eHealthMe is studying from 1,328 Pancuronium users. Check the latest studies of Pancuronium.
What is Sucralfate?
Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.
30 people who take Pancuronium and Sucralfate together, and have interactions are studied.

What are the common drug interactions of Pancuronium and Sucralfate, by gender? *:
female:
- Pyrexia (fever)
- Conjunctivitis (pink eye)
- Constipation
- Pruritus (severe itching of the skin)
- Blood creatinine increased
- Blood lactate dehydrogenase increased
- Lymphocytosis (an increase in the number or proportion of lymphocytes in the blood)
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
- Cardiac failure
- Circulatory collapse
male:
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Cardiac arrest
- Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
- Hypoxia (low oxygen in tissues)
- Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
- Pulmonary oedema (fluid accumulation in the lungs)
What are the common drug interactions of Pancuronium and Sucralfate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Methicillin-resistant staphylococcal aureus infection
- Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
- Acute respiratory distress syndrome
- Adult respiratory distress syndrome (type of lung (pulmonary) failure)
- Cerebral oedema (swelling of brain)
- Hypercapnia (too much smoke)
- Inappropriate adh secretion
- Lower respiratory tract infection
- Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
- Respiratory disorder (respiratory disease)
20-29:
- Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
- Candidal infection (fungal infection)
- Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Pyrexia (fever)
- Blood creatinine increased
- Gamma-glutamyltransferase increased
- Pain
- Rash
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Cardiac arrest
- Chills (felling of cold)
What are the existing conditions these people have? *
- Anaesthesia: 9 people, 30.00%
- Cardiac Failure: 9 people, 30.00%
- Pain: 9 people, 30.00%
- Nausea (feeling of having an urge to vomit): 9 people, 30.00%
- Infection: 9 people, 30.00%
- Electrolyte Imbalance: 9 people, 30.00%
- Urination - Excessive Volume: 8 people, 26.67%
- Bleeding Disorders: 8 people, 26.67%
- Blood Calcium Decreased: 8 people, 26.67%
- Blood Potassium Decreased: 8 people, 26.67%
* Approximation only. Some reports may have incomplete information.
Do you take Pancuronium and Sucralfate?
- Personalize this study to your gender, age, symptoms and drugs (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Pancuronium (1,328 reports)
- Sucralfate (17,548 reports)
Browse all drug interactions of Pancuronium and Sucralfate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pancuronium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sucralfate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pancuronium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sucralfate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pancuronium bromide and sucralfate (the active ingredients of Pancuronium and Sucralfate, respectively), and Pancuronium and Sucralfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Aleve and Bethanechol Chloride - 3 seconds ago
- Could Yasmin cause Pain? - 8 seconds ago
- Could Nitroglycerin cause Rash Pustular? - 12 seconds ago
- Could Desyrel cause Fibula Fracture? - 15 seconds ago
- Drug interactions of Effexor and Mesalamine - 19 seconds ago
- Drug interactions of Escitalopram Oxalate and Darzalex - 19 seconds ago
- Zoledronic Acid and Renal Failure Aggravated for Men aged 50-59 - 29 seconds ago
- Drug interactions of Morphine and Methionine - 36 seconds ago
- Omeprazole and Rytary drug interactions for women aged 60+ - 42 seconds ago
- Could Mucinex Dm cause Limb Injury? - 43 seconds ago